Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: The results of the MitraSwiss registry

Heart

Volumn 99, Issue 14, 2013, Pages 1034-1040

  Sürder, Daniel ^a   Pedrazzini, Giovanni ^a   Gaemperli, Oliver ^b   Biaggi, Patric ^b   Felix, Christian ^b   Rufibach, Kaspar ^c,d   Auf Der Maur, Christof ^e   Jeger, Raban ^f   Buser, Peter ^f   Kaufmann, Beat A ^f   Moccetti, Marco ^a   Hürlimann, David ^b   Bühler, Ines ^b   Bettex, Dominique ^b   Scherman, Jacques ^b   Pasotti, Elena ^a   Faletra, Francesco F ^a   Zuber, Michel ^e   Moccetti, Tiziano ^a   Lüscher, Thomas F ^b   Erne, Paul ^e   Grünenfelder, Jürg ^b   Corti, Roberto ^b   more..

^a DIVISION OF CARDIOLOGY   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d Department of Biostatistics Oncology ^*  (Switzerland)

^e LUZERNER KANTONSSPITAL   (Switzerland)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EUROSCORE; FEMALE; FLUOROSCOPY; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MULTICENTER STUDY; NEW YORK HEART ASSOCIATION CLASS; PREDICTION; PRIORITY JOURNAL; REGISTER; SURVIVAL; SWITZERLAND; TRANSLUMINAL VALVULOPLASTY; TREATMENT RESPONSE;

VALVULAR DISEASE;

AGED; CARDIAC CATHETERIZATION; ECHOCARDIOGRAPHY; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; PROSPECTIVE STUDIES; REGISTRIES; SWITZERLAND; TREATMENT OUTCOME;

EID: 84879691697     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-303105     Document Type: Article

References (28)

1. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11.
2. Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet 2009;373:1382-94.
3. Rosen SE, Borer JS, Hochreiter C, et al. Natural history of the asymptomatic/minimally symptomatic patient with severe mitral regurgitation secondary to mitral valve prolapse and normal right and left ventricular performance. Am J Cardiol 1994;74:374-80.
4. Ling LH, Enriquez-Sarano M, Seward JB, et al. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 1996;335:1417-23.
5. Trichon BH, Felker GM, Shaw LK, et al. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 2003;91:538-43.
6. Agricola E, Ielasi A, Oppizzi M, et al. Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction. Eur J Heart Fail 2009;11:581-7.
7. Pedrazzini GB, Faletra F, Vassalli G, et al. Mitral regurgitation. Swiss Med Wkly 2010;140:36-43.
8. Rossi A, Dini FL, Faggiano P, et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart 2011;97:1675-80.
9. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European society of cardiology. Eur Heart J 2007;28:230-68.
10. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): The joint task force on the management of valvular heart disease of the European society of cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS). Eur Heart J 2012;33:2451-96.
11. Mirabel M, Iung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 2007;28:1358-65.
12. Alfieri O, Maisano F, De Bonis M, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 2001;122:674-81.
13. Feldman T, Kar S, Rinaldi M, et al. Percutaneous mitral repair with the mitraclip system: safety and midterm durability in the initial EVEREST (endovascular valve edge-to-edge repair study) cohort. J Am Coll Cardiol 2009;54:686-94.
14. Pedrazzini GB, Sürder D, Moccetti M, et al. Perkutane katheter-basierte behandlung der schweren mitralinsuffizienz - erste schweizer erfahrungen mit dem mitraclip®-system. Cardiovasc Med 2010;13:122-9.
15. Franzen O, Baldus S, Rudolph V, et al. Acute outcomes of mitraclip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 2010;31:1373-81.
16. Tamburino C, Ussia GP, Maisano F, et al. Percutaneous mitral valve repair with the mitraclip system: acute results from a real world setting. Eur Heart J 2010;31:1382-9.
17. Franzen O, van der Heyden J, Baldus S, et al. MitraClip® therapy in patients with end-stage systolic heart failure. Eur J Heart Fail 2011;13:569-76.
18. Rudolph V, Knap M, Franzen O, et al. Echocardiographic and clinical outcomes of mitraclip therapy in patients not amenable to surgery. J Am Coll Cardiol 2011;58:2190-5.
19. Feldman T, Foster E, Glower DG, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011;364:1395-406.
20. Feldman T, Wasserman HS, Herrmann HC, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST phase I clinical trial. J Am Coll Cardiol 2005;46:2134-40.
21. Auricchio A, Schillinger W, Meyer S, et al. Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by mitraclip improves symptoms and promotes reverse remodeling. J Am Coll Cardiol 2011;58:2183-9.
22. Gaemperli O, Moccetti M, Surder D, et al. Acute haemodynamic changes after percutaneous mitral valve repair: relation to mid-term outcomes. Heart 2012;98:126-132.
23. Siegel RJ, Biner S, Rafique AM, et al. The acute hemodynamic effects of mitraclip therapy. J Am Coll Cardiol 2011;57:1658-65.
24. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography. J Am Soc Echocardiogr 2003;16:777-802.
25. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
26. The criteria committee of the new york heart association. Nomenclature and criteria for diagnosis of diseases of the heart and blood vessels. Boston: Little Brown, 1964.
27. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the valve academic research consortium. Eur Heart J 2011;32:205-17.
28. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials 1996;17:343-6.